Pharmacodynamics and toxicodynamics of drug action : Signaling in cell survival and cell death

• Published in: Pharmaceutical research 1999-06, Vol.16 (6), p.790-798
• Main Authors: KONG, A.-N. T, MANDLEKAR, S, RONG YU, WEI LEI, FASANMANDE, A
• Format: Article
• Language: English
• Subjects: Animals; Antineoplastic agents; Apoptosis; Biological and medical sciences; Calcium-Calmodulin-Dependent Protein Kinases - metabolism; Caspases - metabolism; Cell physiology; Cell Survival - drug effects; Fundamental and applied biological sciences. Psychology; Gene Expression - drug effects; General aspects; Humans; Isothiocyanates - pharmacology; Isothiocyanates - toxicity; JNK Mitogen-Activated Protein Kinases; Medical sciences; Mitogen-Activated Protein Kinases; Molecular and cellular biology; Pharmacology. Drug treatments; Phenols - pharmacology; Phenols - toxicity; Signal Transduction
• ISSN: 0724-8741; 1573-904X
• DOI: 10.1023/A:1011953431486

In therapeutic response to drugs, the plasma concentration range leads to the establishment of a safe and effective dosage regimen. Our hypothesis is that by studying drug concentration-dependent effect on signal transduction mechanisms, a better understanding of the beneficial pharmacodynamic and adverse toxicodynamic responses elicited by the drug may be achieved. Using two classes of chemopreventive compounds (phenolic antioxidants and isothiocyanates), we illustrate the potential utility of two signal transduction pathways elicited by these agents to predict the pharmacodynamic effect (induction of Phase II drug metabolizing enzymes) and the potential toxicodynamic response (stimulation of caspase activity and cytotoxic cell death). At lower concentration, phenolic antioxidants and isothiocyanates activate mitogen-activated protein kinase (MAPK; extracellular signal-regulated protein kinase 2, ERK2; and c-Jun N-terminal kinase 1, JNK1) in a concentration-and time-dependent manner. The activation of MAPK by these compounds may lead to the induction of cell survival/protection genes such as c-jun, c-fos, or Phase II drug metabolizing enzymes. However, at higher concentrations, these agents activate another signaling molecule, ICE/Ced3 cysteine protease enzymes (caspases) leading to apoptotic cell death. The activation of these pathways may dictate the fate of the cells/tissues upon exposure to drugs or chemicals. At lower concentrations, these compounds activate MAPK leading to the induction of Phase II genes, which may protect the cells/tissues against toxic insults and therefore may enhance cell survival. On the other hand, at higher concentrations, these agents may activate the caspases, which may lead to apoptotic cell death, and have toxicity. Understanding the activation of these and other signal transduction events elicited by various drugs and chemicals may yield insights into the regulation of gene expression of drug metabolizing enzymes and cytotoxicity. Thus, the study of signaling events in cell survival (hemeostasis) and cell death (cytotoxicity) may have practical application during pharmaceutical drug development.